3D remodelled DNA helix structure
About us We want to help people do more, feel better, live longer.
Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this.
Read morePress releases
- GSK starts phase III study with mepolizumab in patients with nasal polyps
- GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial
- GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC’s Advisory Meeting
Tweets from GSK
-
GSK @GSK
How can remote communities gain reliable access to clean drinking water? @Khurshid77 has the solution:… twitter.com/i/web/status/8…
about 4 hours ago -
GSK @GSK
Digital technology is helping more and more patients manage their #asthma on the go - find out how ⬇️@Telegraph… twitter.com/i/web/status/8…
about 7 hours ago -
GSK @GSK
A huge congratulations to 2017’s Healthcare Innovation Award winners for their novel solutions to healthcare challe… twitter.com/i/web/status/8…
about 1 day ago
